Health
First U.S. death reported from UK’s new coronavirus strain

WHAT YOU NEED TO KNOW:
- The commissioner of the New Jersey state health department, Judy Persichilli, confirmed that one resident was found positive with the B.1.1.7 and has died in the state.
- The victim was reported to have a history of health problems and did not travel outside of the country.
- The new strain from the U.K. is theorized to be 50 percent more infectious than the earlier COVID-19 variants, and some evidence indicates that it could be more fatal.
On Wednesday, the first recorded death in the U.S from the more transmittable and theoretically more lethal strain of the COVID-19 first discovered in the United Kingdom has been recorded in the state of New Jersey.
The state’s health commissioner, Judy Persichilli, confirmed that one patient was found ill with the strain called B.1.1.7 and also died in there.
During a news conference, Persichilli recommended that
“It’s more important than ever with the variant to continue to mask up, social distance, stay home when you’re sick.”
The health commissioner added that the person had a severe health issue and no recorded trip abroad. On the same day, it was also reported that a total of eight infections were linked to the U.K. strain.
Experts believe the U.K. variant is at least 50 percent more contagious than earlier variants of the bug. There are also indicators that the new mutation could be deadlier than the variant that plagued the U.S.
Officials of the health department have also stressed the available vaccines seemed to be effective against the new strain.
Director of Centers for Disease Control and Prevention (CDC), Rochelle Walensky, also announced on Wednesday that the new variant has surpassed 300 cases across all 26 states.
Walensky explained during a White House COVID-19 presser that
“The variants that have been identified recently seem to spread more easily, they’re more transmissible, which can lead to an increased number of cases and increase stress on our already taxed health care system.”
On Thursday, South Carolina’s health department marked the first case in the U.S. of a more infectious strain called B.1.351. from South Africa.
Health experts say the variant is mainly a concern as early studies have shown a slight drop in the antibody reaction from the vaccines.
Both Moderna and Pfizer said, however, analysis shows their doses can still work against the new virus strain.
Source: The Hill